M&A News: Bain Capital Buys 350-Year-Old Japanese Drugs Firm for $3.4 billion
Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...
Yahoo Finance26d
Bain Capital sweetens buyout offer for Insignia to nearly $1.8bn
US-based Bain Capital has increased its takeover bid for Australian wealth manager Insignia Financial to A$2.87bn ($1.76bn). The offer matches the indicative non-binding buyout offer made last ...
Business Wire2d
Bain Capital Announces Majority Investment in Milacron, a Leading Global Provider of Highly Engineered Plastic Processing Solutions
BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the ...
Reuters27d
Bain Capital raises bid for Australia's Insignia to $1.8 bln, matches CC Capital
Jan 13 (Reuters) - Shares of Australia's Insignia Financial (IFL.AX), opens new tab hit a more than three-year high on Monday as a bidding war escalated, with private equity firm Bain Capital ...